Delivery Order SPE2DB22D1017-SPE2DB25FF7EL

Award Date 3/7/25
Potential Completion Date 3/10/25
Potential Value $2.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,457.00, is for the delivery of the drug Wegovy 0.5 mg/0.5 ml pen in 0.5 ml quantities. The contract is a Firm Fixed Price Delivery Order, with a period of performance through December 31, 2024. The contract does not have a set-aside designation, indicating open competition. In addition to this...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide the drug Wegovy 2.4 mg/0.75 ml pen for a Firm Fixed Price of $5,259.10. The contract has a completion date of February 21, 2024. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award to AmerisourceBergen Drug Corp. is a delivery order valued at $1,958.48 for the supply of the pharmaceutical product Wegovy, a 0.25 mg/0.5 ml pen. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of December 12, 2024. The contract is a firm fixed-price arrangement. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at...
This is a $1,228.50 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of the drug Wegovy 0.5 mg/0.5 ml pen, 0.5 ml, with a period of performance through January 27, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,218.08, is for the supply of Wegovy 1.7 mg/0.75 ml pens. The contract is a Firm Fixed Price type and has an ultimate completion date of February 18, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at...
This is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $24,430.41 and is for the supply of the drug Wegovy 0.5 mg/0.5 ml pen with a completion date of February 5, 2025. This award is associated with AmerisourceBergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,318.90 firm fixed-price delivery order is for the drug Wegovy 2.4 mg/0.75 ml pen 0.75 ml, with a completion date of March 4, 2025. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,270.42, is for the supply of the drug Wegovy (0.5 mg/0.5 ml pen, 0.5 ml) to support military healthcare programs. The contract has an ultimate completion date of November 14, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) that...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, with a ceiling value of $1,228.50, is for the delivery of Wegovy 2.4 mg/0.75 ml pen 0.75 ml, a prescription medication. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,025.14, is for the delivery of Wegovy 2.4 mg/0.75 ml Pen 0.75 ml, a specialty medication. The contract has a firm fixed price and an ultimate completion date of November 28, 2023. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB25FF7EL
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,577.99, is a delivery order for the drug Wegovy 2.4 mg/0.75 ml pen 0.75 ml. The contract has an ultimate completion date of March 10, 2025 and is a firm fixed-price contract. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 6/6/25, 9:44 AM